THE DEAL, AT A GLANCE
From the announcementArrayPatch
What it doesArrayPatch is also developing a treatment for skin cancer and nail fungus.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Who is involvedBacked by Lakeside Capital Ltd, Boole Investment Syndicate, DeepIE Ventures, Enterprise IrelandFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗What happenedArrayPatch raised Seed, announced 2026-11-05From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Why it mattersArrayPatch's seed funding supports advancement of its microneedle therapies toward human trials, with a focus on GLP-1 patches for obesity and diabetes.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
ArrayPatch · Financing Record
Explore source-linked visual explanations for ArrayPatch. Unsupported claims are withheld while source review continues.
Record 15412 · Recorded date: 2026-11-05
Explore company records →